TY - JOUR T1 - Correction: Emerging NK cell therapies for cancer and the promise of next generation engineering of iPSC-derived NK cells JF - Journal for ImmunoTherapy of Cancer JO - J Immunother Cancer DO - 10.1136/jitc-2022-004693corr1 VL - 10 IS - 9 SP - e004693corr1 A2 - , Y1 - 2022/09/01 UR - http://jitc.bmj.com/content/10/9/e004693corr1.abstract ER -